The DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
Open accessAbstract
Spike (S) proteins of coronaviruses, including the coronavirus that causes severe acute respiratory syndrome (SARS), associate with cellular receptors to mediate infection of their target cells. Here we identify a metallopeptidase, angiotensin-converting enzyme 2 (ACE2), isolated from SARS coronavirus (SARS-CoV)-permissive Vero E6 cells, that efficiently binds the S1 domain of the SARS-CoV S protein. We found that a soluble form of ACE2, but not of the related enzyme ACE1, blocked association of the S1 domain with Vero E6 cells. 293T cells transfected with ACE2, but not those transfected with human immunodeficiency virus-1 receptors, formed multinucleated syncytia with cells expressing S protein. Furthermore, SARS-CoV replicated efficiently on ACE2-transfected but not mock-transfected 293T cells. Finally, anti-ACE2 but not anti-ACE1 antibody blocked viral replication on Vero E6 cells. Together our data indicate that ACE2 is a functional receptor for SARS-CoV.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Importantly, ACE2 (angiotensin-converting enzyme 2) had been identified as the receptor for SARS-CoV 4,5 and SARS-CoV-2.”
From COVID-19, Myocarditis and Pericarditis (2023) · cites this paper as [5]
In the citing paper
“Study of Zhou et al.4 indicated that the angiotensin-converting enzyme II (ACE2) is likely the cell receptor of 2019-nCoV, which were also the receptor for SARS-CoV and HCoV-NL637,8.”
From High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa (2020) · cites this paper as [7]
In the citing paper
“The cell surface receptor for the CoV-1 and CoV-2 surface spike protein has been identified by affinity-MS to be angiotensin-converting enzyme 2 (ACE2)147”
From A high-stringency blueprint of the human proteome (2020) · cites this paper as [147]
In the citing paper
“As an alternative approach, cellular interaction partners for a single viral protein of interest have also been investigated by in vitro incubation of the viral protein bait with lysates from uninfected permissive cells.”
From Proteomic approaches to uncovering virus–host protein interactions during the progression of viral infection (2016) · cites this paper as [59]
In the citing paper
“while promoted upon ACE2 overexpression in HEK293T cells that are otherwise non-permissive to SARS-CoV.”
From Proteomic approaches to uncovering virus–host protein interactions during the progression of viral infection (2016) · cites this paper as [59]
In the citing paper
“which was further functionally characterized as a functional receptor for SARS-CoV.”
From Proteomic approaches to uncovering virus–host protein interactions during the progression of viral infection (2016) · cites this paper as [59]
In the citing paper
“MS analysis revealed the cellular metallopeptidase angiotensin-converting enzyme 2 (ACE2) as an S1 interaction partner”
From Proteomic approaches to uncovering virus–host protein interactions during the progression of viral infection (2016) · cites this paper as [59]
In the citing paper
“Viral replication was inhibited upon incubation with antibodies against ACE2”
From Proteomic approaches to uncovering virus–host protein interactions during the progression of viral infection (2016) · cites this paper as [59]
In the citing paper
“This interaction requires cleavage of the S protein, likely by the cell surface protease TMPRSS2, although other proteases (such as Cathepsin B and L, CTSB/CTSL) may also be involved (4-6, 22-25).”
From Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia (2020) · cites this paper as [23]
In the citing paper
“CoV-2 — like SARS-CoV — infects cells through interactions between its spike (S) protein and the ACE2 protein on target cells.”
From Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia (2020) · cites this paper as [23]
In the citing paper
“ACE2 is the functional entry receptor for both severe acute respiratory syndrome (SARS) coronaviruses, SARS-CoV (36) and SARS-CoV-2 (37).”
From TCRD and pharos 2021: mining the human proteome for disease biology (2021) · cites this paper as [36]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of a novel coronavirus in patients with severe acute respiratory syndrome
Drosten, C., Günther, S., Preiser, W., van der Werf, S., Brodt, H.-R., Becker, S., Rabenau, H., Panning, M., Kolesnikova, L., Fouchier, R. A. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030747 · Cited by 4,574
A Novel Coronavirus Associated with Severe Acute Respiratory Syndrome
Tg, K., Erdman, D. D., Cs, G., Zaki, Peret, T. C. T., Emery, S. L., Tong, S., Urbani, C., Comer, J. A., Lim, W., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030781 · Cited by 4,353
Donoghue, M., Hsieh, F., Baronas, E., Godbout, K., Gosselin, M., Stagliano, N., Donovan, M., Woolf, B., Robison, K., Jeyaseelan, R., et al. (2000) · Circulation Research · doi:10.1161/01.res.87.5.e1 · Cited by 2,485
Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome
Rota, P. A., Oberste, M. S., Monroe, S. S., Nix, W. A., Campagnoli, R. P., Icenogle, J. P., Peñaranda, S., Bankamp, B., Maher, K., Chen, M., et al. (2003) · Science · doi:10.1126/science.1085952 · Cited by 2,477
The β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 Isolates
Choe, H., Farzan, M., Sun, Y., Sullivan, N. J., Rollins, B. J., Ponath, P. D., Wu, L., Mackay, C. R., LaRosa, G. J., Newman, W., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81313-6 · Cited by 2,286
Self-citationA Human Homolog of Angiotensin-converting Enzyme
Tipnis, S. R., Hooper, N. M., Hyde, R., Karran, E. H., Christie, G., & Turner, A. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002615200 · Cited by 2,041
The Genome Sequence of the SARS-Associated Coronavirus
Marra, M. A., Jones, S. J. M., Astell, C. R., Holt, R. A., Brooks-Wilson, A. R., Butterfield, Y. S. N., Khattra, J. S., Asano, J. K., Barber, S., Chan, S. Y., et al. (2003) · Science · doi:10.1126/science.1085953 · Cited by 2,027
Angiotensin-converting enzyme 2 is an essential regulator of heart function
Crackower, M. A., Sarao, R., Oudit, G. Y., Yagil, C., Kozieradzki, I., Scanga, S. E., Oliveira-dos-Santos, A. J., da Costa, J., Zhang, L., Pei, Y., et al. (2002) · Nature · doi:10.1038/nature00786 · Cited by 1,733
Hydrolysis of Biological Peptides by Human Angiotensin-converting Enzyme-related Carboxypeptidase
Vickers, C., Hales, P., Kaushik, V. K., Dick, L. R., Gavin, J. M., Tang, J., Godbout, K., Parsons, T. F., Baronas, E., Hsieh, F., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200581200 · Cited by 1,406
Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome
Kuiken, T., Fouchier, R. A. M., Schutten, M., Rimmelzwaan, G. F., van Amerongen, G., van Riel, D. A. J., Laman, J. D., de Jong, T., van Doornum, G., Lim, W. W. L., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13967-0 · Cited by 1,015
Cited by
Sorted by citations
Items 801–900 of 1,026
Impaired angiogenesis in aminopeptidase N-null mice
Rangel, R., Sun, Y. K., Guzman‐Rojas, L., Ozawa, M. G., Sun, J. D., Giordano, R. J., Pelt, C. S. V., Tinkey, P. T., Behringer, R. R., Sidman, R. L., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611653104 · Cited by 131
Magro, G. (2020) · Virus Research · doi:10.1016/j.virusres.2020.198070 · Cited by 131
Tomato (Solanum lycopersicum L.) seed: A review on bioactives and biomedical activities
Kumar, M., Tomar, M., Bhuyan, D. J., Punia, S., Grasso, S., Sá, A. G. A., Carciofi, B. A. M., Arrutia, F., Changan, S., Radha, et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112018 · Cited by 130
Haga, S., Nagata, N., Okamura, T., Yamamoto, N., Sata, T., Yamamoto, N., Sasazuki, T., & Ishizaka, Y. (2009) · Antiviral Research · doi:10.1016/j.antiviral.2009.12.001 · Cited by 130
He, Y., Zhou, Y., Siddiqui, P., & Jiang, S. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.10.052 · Cited by 130
Interaction of severe acute respiratory syndrome-associated coronavirus with dendritic cells
Spiegel, M., Schneider, K., Weber, F., Weidmann, M., & Hufert, F. T. (2006) · Journal of General Virology · doi:10.1099/vir.0.81624-0 · Cited by 130
Mackey, K., King, V. J., Gurley, S. B., Kiefer, M., Liederbauer, E., Vela, K., Sonnen, P., & Kansagara, D. L. (2020) · Annals of Internal Medicine · doi:10.7326/m20-1515 · Cited by 130
Vishnubalaji, R., Shaath, H., & Alajez, N. M. (2020) · Genes · doi:10.3390/genes11070760 · Cited by 130
Molnupiravir: A new candidate for COVID‐19 treatment
Pourkarim, F., Pourtaghi‐Anvarian, S., & Rezaee, H. (2021) · Pharmacology Research & Perspectives · doi:10.1002/prp2.909 · Cited by 130
Durai, P., Batool, M., Shah, M., & Choi, S. (2015) · Experimental & Molecular Medicine · doi:10.1038/emm.2015.76 · Cited by 129
Lambert, D., Clarke, N. E., Hooper, N. M., & Turner, A. J. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.11.085 · Cited by 129
Treatment of severe acute respiratory syndrome
Lai, S. T. (2005) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-005-0004-z · Cited by 129
Sheahan, T. P., Rockx, B., Donaldson, E., Sims, A. M., Pickles, R. J., Corti, D., & Baric, R. S. (2007) · Journal of Virology · doi:10.1128/jvi.02041-07 · Cited by 129
Unraveling the Possible Routes of SARS-COV-2 Invasion into the Central Nervous System
Lima, M., Siokas, V., Aloizou, A., Liampas, I., Mentis, A. A., Tsouris, Z., Papadimitriou, A., Mitsias, P. D., Tsatsakis, A. M., Bogdanos, D. P., et al. (2020) · Current Treatment Options in Neurology · doi:10.1007/s11940-020-00647-z · Cited by 129
SARS-CoV-2 spike engagement of ACE2 primes S2′ site cleavage and fusion initiation
Yu, S., Zheng, X., Zhou, B., Li, J., Chen, M., Deng, R. X., Wong, G., Lavillette, D., & Meng, G. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2111199119 · Cited by 130
SARS–associated Coronavirus Replication in Cell Lines
Kaye, M., Druce, J. D., Tran, T., Kostecki, R., Chibo, D., Morris, J. L., Catton, M. G., & Birch, C. J. (2006) · Emerging infectious diseases · doi:10.3201/eid1201.050496 · Cited by 128
Kuhn, J. H., Radoshitzky, S. R., Guth, A. C., Warfield, K. L., Li, W., Vincent, M. J., Towner, J. S., Nichol, S. T., Bavari, S., Choe, H., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601796200 · Cited by 128
Self-citationProtease-Mediated Entry via the Endosome of Human Coronavirus 229E
Kawase, M., Shirato, K., Matsuyama, S., & Taguchi, F. (2008) · Journal of Virology · doi:10.1128/jvi.01933-08 · Cited by 128
Murine Coronavirus with an Extended Host Range Uses Heparan Sulfate as an Entry Receptor
de Haan, C. A. M., Li, Z., Lintelo, E. G. T., Bosch, B., Haijema, B. J., & Rottier, P. J. M. (2005) · Journal of Virology · doi:10.1128/jvi.79.22.14451-14456.2005 · Cited by 128
Elfiky, A. A., Mahdy, S. M., & Elshemey, W. M. (2016) · Journal of Medical Virology · doi:10.1002/jmv.24736 · Cited by 128
Pyroptosis-Induced Inflammation and Tissue Damage
Wei, Y., Yang, L., Pandeya, A., Cui, J., Zhang, Y., & Li, Z. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.167301 · Cited by 130
Du, L., Zhao, G., Chan, C. C. S., Sun, S., Chen, M., Liu, Z., Guo, H., He, Y., Zhou, Y., Zheng, B., et al. (2009) · Virology · doi:10.1016/j.virol.2009.07.018 · Cited by 127
Recently Discovered Human Coronaviruses
Wevers, B. A., & van der Hoek, L. (2009) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2009.07.007 · Cited by 127
Zhao, X., Sehgal, M., Hou, Z., Cheng, J., Shu, S., Wu, S., Guo, F., Marchand, S. J. L., Lin, H., Chang, J., et al. (2017) · Journal of Virology · doi:10.1128/jvi.01535-17 · Cited by 127
Mu, C., Sheng, Y., Wang, Q., Amin, A., Li, X., & Xie, Y. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2020.104149 · Cited by 127
A serum-stable RNA aptamer specific for SARS-CoV-2 neutralizes viral entry
Valero, J., Civit, L., Dupont, D. M., Selnihhin, D., Reinert, L. S., Idorn, M., Israels, B. A., Bednarz, A., Bus, C., Asbach, B., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2112942118 · Cited by 127
Simmons, G., Bertram, S., Glowacka, I., Steffen, I., Chaipan, C., Agudelo, J., Lü, K., Rennekamp, A. J., Hofmann, H., Bates, P. F., et al. (2011) · Virology · doi:10.1016/j.virol.2011.02.020 · Cited by 126
Principles of Virus Uncoating: Cues and the Snooker Ball
Yamauchi, Y., & Greber, U. F. (2016) · Traffic · doi:10.1111/tra.12387 · Cited by 127
Mendonca, P., & Soliman, K. F. A. (2020) · Antioxidants · doi:10.3390/antiox9080659 · Cited by 126
Li, W., Chen, Y., Prévost, J., Ullah, I., Lu, M., Gong, S. Y., Tauzin, A., Gasser, R., Vézina, D., Anand, S. P., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.110210 · Cited by 128
Self-citationClinical Insights into the Gastrointestinal Manifestations of COVID-19
Kopel, J. J., Perisetti, A., Gajendran, M., Boregowda, U. N., & Goyal, H. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06362-8 · Cited by 125
SARS-CoV-2 in children: spectrum of disease, transmission and immunopathological underpinnings
Williams, P. C. M., Howard‐Jones, A. R., Hsu, P. S., Palasanthiran, P., Gray, P. E., McMullan, B. J., Britton, P. N., & Bartlett, A. W. (2020) · Pathology · doi:10.1016/j.pathol.2020.08.001 · Cited by 125
Cholesterol-Rich Lipid Rafts as Platforms for SARS-CoV-2 Entry
Palacios-Rápalo, S. N., Jesús‐González, L. A. D., Cordero‐Rivera, C. D., Farfán-Morales, C. N., Osuna‐Ramos, J. F., Martínez-Mier, G., Quistián-Galván, J., Muñoz-Pérez, A., Bernal-Dolores, V., del Ángel, R. M., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.796855 · Cited by 125
Hofmann, H., Simmons, G., Rennekamp, A. J., Chaipan, C., Gramberg, T., Heck, E., Geier, M., Wegele, A., Marzi, A., Bates, P. F., et al. (2006) · Journal of Virology · doi:10.1128/jvi.00560-06 · Cited by 124
Du, L., Tai, W., Yang, Y., Zhao, G., Zhu, Q., Sun, S., Liu, C., Tao, X., Tseng, C.-T. K., Perlman, S. M., et al. (2016) · Nature Communications · doi:10.1038/ncomms13473 · Cited by 124
Li, R., Qiao, S., & Zhang, G. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.02.013 · Cited by 125
Conformational transition of SARS-CoV-2 spike glycoprotein between its closed and open states
Gür, M., Taka, E., Yilmaz, S. Z., Kılınç, C., Aktas, U., & Gölcük, M. (2020) · The Journal of Chemical Physics · doi:10.1063/5.0011141 · Cited by 126
Pišlar, A. H., Mitrović, A., Sabotič, J., Fonović, U. P., Nanut, M. P., Jakoš, T., Senjor, E., & Kos, J. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1009013 · Cited by 124
Wang, S., Li, W., Wang, Z., Yang, W., Li, E., Xia, X., Yan, F., & Chiu, S. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01917-x · Cited by 124
Self-citationde Lang, A., Osterhaus, A. D. M. E., & Haagmans, B. L. (2006) · Virology · doi:10.1016/j.virol.2006.06.011 · Cited by 123
Guy, J. L., Jackson, R. M., Jensen, H. A., Hooper, N. M., & Turner, A. J. (2005) · FEBS Journal · doi:10.1111/j.1742-4658.2005.04756.x · Cited by 123
Inhibitor Recognition Specificity of MERS-CoV Papain-like Protease May Differ from That of SARS-CoV
Lee, H., Lei, H., Santarsiero, B. D., Gatuz, J. L., Cao, S., Rice, A. J., Patel, K., Szypulinski, M. Z., Ojeda, I., Ghosh, A. K., et al. (2015) · ACS Chemical Biology · doi:10.1021/cb500917m · Cited by 123
Vaccination strategies to combat novel corona virus SARS-CoV-2
Pandey, S. C., Pande, V., Sati, D., Upreti, S., & Samant, M. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117956 · Cited by 125
Gender susceptibility to COVID-19: a review of the putative role of sex hormones and X chromosome
Foresta, C., Rocca, M. S., & Nisio, A. D. (2020) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01383-6 · Cited by 124
Ren, W., Li, W., Yu, M., Hao, P., Zhang, Y., Zhou, P., Zhang, S., Zhao, G., Zhong, Y., Wang, S., et al. (2006) · Journal of General Virology · doi:10.1099/vir.0.82220-0 · Cited by 122
Self-citationMicroRNome Analysis Unravels the Molecular Basis of SARS Infection in Bronchoalveolar Stem Cells
Mallick, B., Ghosh, Z., & Chakrabarti, J. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007837 · Cited by 122
Molecular biology of coronaviruses: current knowledge
Artika, I. M., Dewantari, A. K., & Wiyatno, A. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e04743 · Cited by 122
Potential zoonotic sources of SARS‐CoV‐2 infections
Jo, W. K., de Oliveira-Filho, E. F., Rasche, A., Greenwood, A. D., Osterrieder, N., & Drexler, J. F. (2020) · Transboundary and Emerging Diseases · doi:10.1111/tbed.13872 · Cited by 122
Bibliometric analysis of global scientific research on Coronavirus (COVID-19)
Dehghanbanadaki, H., Seif, F., Vahidi, Y., Razi, F., Hashemi, E., Khoshmirsafa, M., & Aazami, H. (2020) · Medical Journal of the Islamic Republic of Iran · doi:10.47176/mjiri.34.51 · Cited by 122
A Comprehensive Review About SARS-CoV-2
Haque, S. M., Ashwaq, O., Sarief, A., & Azad John Mohamed, A. K. (2020) · Future Virology · doi:10.2217/fvl-2020-0124 · Cited by 121
Anti-SARS coronavirus agents: a patent review (2008 – present)
Kumar, V., Jung, Y., & Liang, P. (2013) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2013.823159 · Cited by 121
Spruth, M., Kistner, O., Savidis-Dacho, H., Hitter, E., Crowe, B. A., Gerenčer, M., Brühl, P., Grillberger, L., Reiter, M., Tauer, C., et al. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.08.055 · Cited by 121
Shang, J., Wang, Q., Zhang, H., Wang, X., Wan, J., Yan, Y., Gao, Y., Cheng, J., Li, Z., & Lin, J. (2020) · The American Journal of Medicine · doi:10.1016/j.amjmed.2020.05.033 · Cited by 121
Yan, H., Jiao, H., Liu, Q., Zhang, Z., Xiong, Q., Wang, B.-J., Wang, X., Guo, M. S., Wang, L., Lan, K., et al. (2021) · Nature Ecology & Evolution · doi:10.1038/s41559-021-01407-1 · Cited by 121
Kumar, A., Ishida, R., Strilets, T., Cole, J., López-Orozco, J., Fayad, N., Felix-Lopez, A., Elaish, M., Evseev, D., Magor, K. E., et al. (2021) · Journal of Virology · doi:10.1128/jvi.00266-21 · Cited by 122
SARS-CoV replication and pathogenesis in an in vitro model of the human conducting airway epithelium
Sims, A. M., Burkett, S. E., Yount, B. L., & Pickles, R. J. (2007) · Virus Research · doi:10.1016/j.virusres.2007.03.013 · Cited by 120
The flexibility of ACE2 in the context of SARS-CoV-2 infection
de Barros, E. P., Casalino, L., Gaieb, Z., Dommer, A. C., Wang, Y., Fallon, L., Raguette, L. E., Belfon, K. A. A., Simmerling, C. L., & Amaro, R. E. (2020) · Biophysical Journal · doi:10.1016/j.bpj.2020.10.036 · Cited by 120
Supekar, V. M., Bruckmann, C., Ingallinella, P., Bianchi, E., Pessi, A., & Carfı́, A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406128102 · Cited by 120
Abraham, J., Kwong, J. A., Albariño, C. G., Lu, J., Radoshitzky, S. R., Salazar-Bravo, J. A., Farzan, M., Spiropoulou, C. F., & Choe, H. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000358 · Cited by 120
Self-citationTundo, G. R., Sbardella, D., Santoro, A. M., Coletta, A., Oddone, F., Grasso, G., Milardi, D., Lacal, P. M., Marini, S., Purrello, R., et al. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107579 · Cited by 120
Carrillo, J., Izquierdo‐Useros, N., Ávila‐Nieto, C., Pradenas, E., Clotet, B., & Blanco, J. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.10.108 · Cited by 120
Analysis of COVID‐19 vaccines: Types, thoughts, and application
Han, X., Xu, P., & Ye, Q. (2021) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.23937 · Cited by 119
He, Y., Li, J., Li, W., Lustigman, S., Farzan, M., & Jiang, S. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.10.6085 · Cited by 118
Self-citationBiomarkers of COVID-19 and technologies to combat SARS-CoV-2
Zhang, L., & Guo, H. (2020) · Advances in Biomarker Sciences and Technology · doi:10.1016/j.abst.2020.08.001 · Cited by 118
Immunosuppressive Drugs and COVID-19: A Review
Schoot, T. S., Kerckhoffs, A. P. M., Hilbrands, L. B., & van Marum, R. J. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01333 · Cited by 118
Singh, A. K., Jena, A., Kumar, P. M., Sharma, V., & Sebastian, S. (2020) · United European Gastroenterology Journal · doi:10.1177/2050640620972602 · Cited by 118
Esparza, T. J., Martin, N. P., Anderson, G. P., Goldman, E. R., & Brody, D. L. (2020) · Scientific Reports · doi:10.1038/s41598-020-79036-0 · Cited by 118
Song, X., Hu, W., Yu, H., Zhao, L., Zhao, Y., Zhao, X., Xue, H., & Zhao, Y. (2023) · Cytometry Part A · doi:10.1002/cyto.a.24285 · Cited by 117
Characterization of viral proteins encoded by the SARS-coronavirus genome
Tan, Y., Lim, S. G., & Hong, W. (2004) · Antiviral Research · doi:10.1016/j.antiviral.2004.10.001 · Cited by 117
Pathology of Experimental SARS Coronavirus Infection in Cats and Ferrets
van den Brand, J. M. A., Haagmans, B. L., Leijten, L. M. E., van Riel, D. A. J., Martina, B. E. E., Osterhaus, A. D. M. E., & Kuiken, T. (2008) · Veterinary Pathology · doi:10.1354/vp.45-4-551 · Cited by 117
Ragia, G., & Manolopoulos, V. G. (2020) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-020-02963-4 · Cited by 117
Repurposing Drugs, Ongoing Vaccine, and New Therapeutic Development Initiatives Against COVID-19
Saha, R. P., Sharma, A. R., Singh, M. K., Samanta, S., Bhakta, S., Mandal, S., Bhattacharya, M., Lee, S. S., & Chakraborty, C. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01258 · Cited by 118
Chloroquine and hydroxychloroquine in the treatment of malaria and repurposing in treating COVID-19
Lei, Z., Wu, Z., Dong, S., Yang, D., Zhang, L., Ke, Z., Zou, C., & Chen, Z. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107672 · Cited by 117
High affinity binding of SARS-CoV-2 spike protein enhances ACE2 carboxypeptidase activity
Lu, J., & Sun, P. D. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.015303 · Cited by 118
Furin cleavage sites naturally occur in coronaviruses
Wu, Y., & Zhao, S. (2021) · Stem Cell Research · doi:10.1016/j.scr.2020.102115 · Cited by 117
A Review on SERS-Based Detection of Human Virus Infections: Influenza and Coronavirus
Saviñon-Flores, F., Méndez, E., López-Castaños, M., Carabarín‐Lima, A., López-Castaños, K. A., González‐Fuentes, M. A., & Méndez‐Albores, A. (2021) · Biosensors · doi:10.3390/bios11030066 · Cited by 117
Plasma ACE2 predicts outcome of COVID-19 in hospitalized patients
Kragstrup, T. W., Singh, H. S., Grundberg, I., Nielsen, A. L., Rivellese, F., Mehta, A., Goldberg, M. B., Filbin, M. R., Qvist, P., & Bibby, B. M. (2021) · PLoS ONE · doi:10.1371/journal.pone.0252799 · Cited by 117
Therapeutic targets and interventional strategies in COVID-19: mechanisms and clinical studies
Zhou, Y., Xie, Y., Tang, L., Pu, D., Zhu, Y., Liu, J., & Ma, X. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00733-x · Cited by 116
Assembly of human severe acute respiratory syndrome coronavirus-like particles
Ho, Y.-H., Lin, P.-H., Liu, C. Y. Y., Lee, S.-P., & Chao, Y. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.04.111 · Cited by 117
Mechanisms of Severe Acute Respiratory Syndrome Pathogenesis and Innate Immunomodulation
Frieman, M. B., & Baric, R. S. (2008) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00015-08 · Cited by 117
Identification of the Fusion Peptide-Containing Region in Betacoronavirus Spike Glycoproteins
Ou, X., Zheng, W., Shan, Y., Mu, Z., Dominguez, S. R., Holmes, K. V., & Qian, Z. (2016) · Journal of Virology · doi:10.1128/jvi.00015-16 · Cited by 116
Tripathy, S., Dassarma, B., Roy, S., Chabalala, H. P., & Matsabisa, M. G. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.106028 · Cited by 116
Jung, S., Choi, J. C., You, S., & Kim, W. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa624 · Cited by 116
Pan, B., Fang, S., Zhang, J., Pan, Y., Liu, H., Wang, Y., Li, M., & Liu, L. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.11.010 · Cited by 116
Lifestyle factors in the prevention of COVID-19
Lange, K. W., & Nakamura, Y. (2020) · Global Health Journal · doi:10.1016/j.glohj.2020.11.002 · Cited by 119
Structures of a deltacoronavirus spike protein bound to porcine and human receptors
Ji, W., Peng, Q., Fang, X., Li, Z., Li, Y., Xu, C., Zhao, S., Li, J., Chen, R., Mo, G., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29062-5 · Cited by 118
Bosch, B., Bodewes, R., de Vries, R. P., Kreijtz, J. H. C. M., Bartelink, W., van Amerongen, G., Rimmelzwaan, G. F., de Haan, C. A. M., Osterhaus, A. D. M. E., & Rottier, P. J. M. (2010) · Journal of Virology · doi:10.1128/jvi.01035-10 · Cited by 116
Wang, Z., Ren, L., Zhao, X., Hung, T., Meng, A., Wang, J., & Chen, Y. (2004) · Journal of Virology · doi:10.1128/jvi.78.14.7523-7527.2004 · Cited by 116
Yuan, X., Wu, J., Shan, Y., Yao, Z., Dong, B., Chen, B., Zhao, Z., Wang, S., Chen, J., & Cong, Y. (2005) · Virology · doi:10.1016/j.virol.2005.10.015 · Cited by 115
Wu, Y. (2020) · Virologica Sinica · doi:10.1007/s12250-020-00205-6 · Cited by 115
Sharma, A., Jaiswal, P., Kerakhan, Y., Saravanan, L., Murtaza, Z., Zergham, A. S., Honganur, N.-S., Akbar, A., Deol, A., Francis, B., et al. (2020) · Annals of Hepatology · doi:10.1016/j.aohep.2020.10.001 · Cited by 115
Hempel, T., Raich, L., Olsson, S., Azouz, N. P., Klingler, A. M., Hoffmann, M., Pöhlmann, S., Rothenberg, M. E., & Noé, F. (2020) · Chemical Science · doi:10.1039/d0sc05064d · Cited by 115
Potential Interaction Between SARS-CoV-2 and Thyroid: A Review
Chen, W., Tian, Y., Li, Z., Zhu, J., Wei, T., & Lei, J. (2021) · Endocrinology · doi:10.1210/endocr/bqab004 · Cited by 115
A human SARS-CoV neutralizing antibody against epitope on S2 protein
Duan, J., Yan, X., Guo, X., Cao, W., Han, W., Qi, C., Feng, J., Yang, D., Gao, G., & Jin, G. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.05.089 · Cited by 114
Hoffmann, M., Müller, M. A., Drexler, J. F., Glende, J., Erdt, M., Gützkow, T., Losemann, C., Binger, T., Deng, H., Schwegmann‐Weßels, C., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072942 · Cited by 114
Rivière, G., Michaud, A., Breton, C., Camp, G. V., Laborie, C., Enache, M., Lésage, J., DELOOF, S., Corvol, P. L., & Vieau, D. (2005) · Hypertension · doi:10.1161/01.hyp.0000185148.27901.fe · Cited by 114
COVID-19, MERS and SARS with Concomitant Liver Injury—Systematic Review of the Existing Literature
Kukla, M., Skonieczna‐Żydecka, K., Kotfis, K., Maciejewska, D., Łoniewski, I., Lara, L. F., Pazgan−Simon, M., Stachowska, E., Kaczmarczyk, M., Koulaouzidis, A., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051420 · Cited by 115
Advances in research on ACE2 as a receptor for 2019-nCoV
Wu, J., Deng, W., Li, S., & Yang, X. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03611-x · Cited by 114
Sialic acid O-acetylation: From biosynthesis to roles in health and disease
Visser, E. A., Moons, S. J., Timmermans, S. B. P. E., de Jong, H., Boltje, T. J., & Büll, C. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100906 · Cited by 117
Memory B cell repertoire for recognition of evolving SARS-CoV-2 spike
Tong, P., Gautam, A. K., Windsor, I. W., Travers, M. E., Chen, Y., Garcia, N., Whiteman, N. B., McKay, L. G. A., Storm, N., Malsick, L. E., et al. (2021) · Cell · doi:10.1016/j.cell.2021.07.025 · Cited by 115
Metadata
- Authors
- Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., Choe, H., & Farzan, M.
- Affiliations
- Brigham and Women's Hospital (US)
- Harvard University (US)
- Tufts University (US)
- University of Massachusetts Chan Medical School (US)
- Corresponding author
- Choe, Hyeryun
- Farzan, Michael
- ORCID
- Venue
- Nature
- Published
- 2003-11-27
- Volume
- 426
- Issue
- 6965
- Pages
- 450-454
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC7095016
- OpenAlex
- W1966238900
- Cited by
- 5,923
- References
- 32
- Citations by year
- 2026: 74 · 2025: 145 · 2024: 298 · 2023: 448 · 2022: 732 · 2021: 1288 · 2020: 1794 · 2019: 32 · 2018: 30 · 2017: 44 · 2016: 50 · 2015: 49 · 2014: 62 · 2013: 43 · 2012: 50
- FWCI
- 79.30
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Nature (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- The Journal of the American Medical Association (JAMA) Network (American Medical Association) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Science Foundation
- National Aeronautics and Space Administration
- Hawaii Community Foundation
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
- Keywords
- angiotensin-converting enzyme 2, SARS coronavirus, viral receptor, receptor binding, syncytium formation, viral replication, ACE1, Vero E6 cells, HEK293T cells, antibody inhibition
- MeSH terms
- Angiotensin-Converting Enzyme 2, Animals, Antibodies, Carboxypeptidases, Cell Line, Chlorocebus aethiops, Humans, Peptidyl-Dipeptidase A, Membrane Glycoproteins, Molecular Weight, Protein Binding, Receptors, Virus, Solubility, Transfection, Vero Cells, Viral Envelope Proteins, Virus Replication, Giant Cells, Protein Structure, Tertiary, Severe acute respiratory syndrome-related coronavirus, Spike Glycoprotein, Coronavirus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
